Asco 2025 · Posters · Tumores del Sistema Nervioso Central · Juan Manuel Sepulveda, MD, PhD Volver

Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Preliminary results of phase Ib/II CAN-201 NDG trial.

Abstract: 2069
Poster Bd #: 115
Descargar Poster

Juan Manuel Sepulveda, MD, PhD

Medical Oncology Service. Hospital Universitario 12 de Octubre, Madrid.

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo